Stryker Corporation (SYK) : Rosenbaum Jay D. scooped up 546 additional shares in Stryker Corporation during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Apr 20, 2016. The investment management firm now holds a total of 13,392 shares of Stryker Corporation which is valued at $1,465,085.Stryker Corporation makes up approximately 0.27% of Rosenbaum Jay D.’s portfolio.
Stryker Corporation opened for trading at $109.44 and hit $110.06 on the upside on Friday, eventually ending the session at $109.4, with a gain of 0.08% or 0.09 points. The heightened volatility saw the trading volume jump to 18,37,756 shares. Company has a market cap of $40,804 M.
Other Hedge Funds, Including , Regent Investment Management reduced its stake in SYK by selling 200 shares or 3.08% in the most recent quarter. The Hedge Fund company now holds 6,300 shares of SYK which is valued at $689,220. Stryker Corporation makes up approx 0.38% of Regent Investment Management’s portfolio.Wendell David Associates Inc reduced its stake in SYK by selling 2,488 shares or 1.85% in the most recent quarter. The Hedge Fund company now holds 132,219 shares of SYK which is valued at $14,464,759. Stryker Corporation makes up approx 2.79% of Wendell David Associates Inc’s portfolio.
On the company’s financial health, Stryker Corporation reported $1.24 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Apr 20, 2016. Analyst had a consensus of $1.20. The company had revenue of $2495.00 million for the quarter, compared to analysts expectations of $2471.86 million. The company’s revenue was up 4.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.11 EPS.
Many Wall Street Analysts have commented on Stryker Corporation. Company shares were Reiterated by RBC Capital Mkts on Apr 26, 2016 to “Outperform”, Firm has raised the Price Target to $ 120 from a previous price target of $108 .Company shares were Downgraded by Robert W. Baird on Apr 13, 2016 to ” Neutral”, Firm has raised the Price Target to $ 116 from a previous price target of $111 .Barclays Resumed Stryker Corporation on Apr 11, 2016 to “Underweight”, Price Target of the shares are set at $107.
Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics Medical and Surgical and Neurotechnology and Spine which help improve patient and hospital outcomes.